These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31726197)

  • 1. Design of Coenzyme Q10 solid dispersion for improved solubilization and stability.
    Choi JS; Park JW; Park JS
    Int J Pharm; 2019 Dec; 572():118832. PubMed ID: 31726197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation.
    Nepal PR; Han HK; Choi HK
    Int J Pharm; 2010 Jan; 383(1-2):147-53. PubMed ID: 19781608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of Ethylene Oxide-co-propylene Oxide for Dissolution Enhancement of Hot-Melt Extruded Solid Dispersions.
    Hurley D; Potter CB; Walker GM; Higginbotham CL
    J Pharm Sci; 2018 May; 107(5):1372-1382. PubMed ID: 29410037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
    Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats.
    Choi JS; Ahn JB; Park JS
    Int J Pharm; 2019 Jan; 555():135-145. PubMed ID: 30458259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
    El-Bary AA; Al Sharabi I; Haza'a BS
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of scCO
    Yang R; Li Y; Li J; Liu C; Du P; Zhang T
    Drug Dev Ind Pharm; 2018 Feb; 44(2):289-295. PubMed ID: 29082762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
    Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
    Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.
    Tang J; Bao J; Shi X; Sheng X; Su W
    J Microencapsul; 2018 Aug; 35(5):454-466. PubMed ID: 30229692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluation.
    Wairkar S; Gaud R; Jadhav N
    J Pharm Pharmacol; 2017 Sep; 69(9):1099-1109. PubMed ID: 28590055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate.
    Choi JS; Park JS
    Eur J Pharm Sci; 2017 Jan; 97():269-276. PubMed ID: 27919702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and evaluation of coenzyme Q10 binary solid dispersions for enhanced solubility and dissolution.
    Bhandari KH; Newa M; Kim JA; Yoo BK; Woo JS; Lyoo WS; Lim HT; Choi HG; Yong CS
    Biol Pharm Bull; 2007 Jun; 30(6):1171-6. PubMed ID: 17541177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel.
    Chen J; Qiu L; Hu M; Jin Y; Han J
    Drug Dev Ind Pharm; 2008 Jun; 34(6):588-94. PubMed ID: 18568908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies.
    McFall H; Sarabu S; Shankar V; Bandari S; Murthy SN; Kolter K; Langley N; Kim DW; Repka MA
    Int J Pharm; 2019 Jan; 554():302-311. PubMed ID: 30395959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers.
    Friedrich H; Fussnegger B; Kolter K; Bodmeier R
    Eur J Pharm Biopharm; 2006 Feb; 62(2):171-7. PubMed ID: 16275049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution enhancement of atorvastatin calcium by co-grinding technique.
    Prabhu P; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):380-91. PubMed ID: 26712124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of solid dispersion to improve dissolution and oral bioavailability of poorly soluble dexibuprofen.
    Tran P; Park JS
    Pharm Dev Technol; 2021 Apr; 26(4):422-430. PubMed ID: 33543664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.